Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Bullboard Posts
Comment by 2b7f6fabon Aug 30, 2017 1:20pm
177 Views
Post# 26637963

RE:No PP before Spring 2018....

RE:No PP before Spring 2018....If only that were true. Unfortunately, the MDA has an error in working capital where total assets were used instead of current assets. So you can deduct $753,766 representing Property and Equipment which is not part of working capital. . Inventories and Prepaid Expenses are part of working capital but those amounts are not available to spend. So you can also deduct them from your computation below (approx. $1,351,729). And let's deduct another $1 million for July and Aug Opex and Capex (est) brings us to a approx. $1.5 million here at the end of August. (I know a good CPA who would work for options only, and a place to live since Toronto isn't cheap. :)
wildbird1 wrote:
All the numbers below came from....
1) The condensed Interim Consolidated Financial Statements, dated June 30,2017.
2) MD&A (Management Discussion and Analysis) dated August 29,2017.

First what is Working Capital???...
Working Capital is a mesure of cash and liquid assets to fund a Company day-to-day operations.

As of June 30,2017 TLT has a Working Capital of $3,789,581.

To this amount you have to add the money that came in after June 30,2017.

1) on July 30,2017.......$9,375........from....... 25,000 Warrants.
2) on August 4,2017....$375,000....from...1,000,000 Warrants.
3) on August 24,2017..$468,750....from... 1,250,000 Warrants

Total Working Capital = $3,789,581 + $853,125 (Warrants) = $4,642,706.

More than enough money to carry TLT into the Spring of 2018.

More  money could come in from future Warrants being exercised (very big possibility).

In the MD$A (dated August 29,2017) TLT said (Quote) ''Management believe that the Company has sufficient cash on hand to meet its operating and Working capital''(End of Quote).


See you in 2018... For more Money.







Bullboard Posts